Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Licensing revenue		$ 500,000
Operating expenses:
Research and development	11,287,691	11,733,666
General and administrative	9,742,739	13,687,899
Total operating expenses	21,030,430	25,421,565
Loss from operations	(21,030,430)	(24,921,565)
Other income (expense):
Gain from change in earn-out milestone liability		5,396,000
Impairment of in-process research and development		(13,366,234)
Loss on debt extinguishment	(329,158)
Investment income, net	1,157,625	453,356
Interest expense	(197,080)	(5,028,618)
Other (loss) income	(396,319)	1,801
Total other income (expense), net	235,068	(12,543,695)
Loss before income tax benefit	(20,795,362)	(37,465,260)
Income tax benefit	1,280,385	1,567,026
Net loss	$ (19,514,977)	$ (35,898,234)
Net loss per common share - Basic	$ (2.16)	$ (5.03)
Net loss per common share - Diluted	$ (2.16)	$ (5.03)
Weighted average common shares outstanding - Basic	9,045,320	7,142,970
Weighted average common shares outstanding - Diluted	9,045,320	7,142,970